Development of the retinoic acid receptor alpha-specific antagonist YCT-529 for male contraception: A brief review

Shi, R., Wolgemuth, D. J., & Georg, G. I. (2025). Development of the retinoic acid receptor alpha-specific antagonist YCT-529 for male contraception: A brief review. Contraception, 110809. https://doi.org/10.1016/j.contraception.2024.110809
Authors:
Rui Shi
Debra J Wolgemuth
Gunda I Georg
Affiliated Authors:
Debra J Wolgemuth
Columbia Affiliation:
Author Keywords:
antagonist
male contraception
reversibility
spermatogenesis inhibition
vitamin a
elink
Publication Type:
Article
Unique ID:
10.1016/j.contraception.2024.110809
PMID:
39756562
DOI:
10.1016/j.contraception.2024.110809
Journal:
Contraception
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: